Abstract

Pre-implantation genetic testing for aneuploidy PGT-A is a genetic test performed on Day 5 or Day 6 embryos obtained through Invitro fertilization (IVF). Embryo Biopsy is a procedure where the part of Trophoectoderm of the embryo is taken and sent for PGT-A analysis. PGT-A is indicated in couple who has been through previous miscarriage, maternal age >35 years and previous child anomalies. Mosaicism is a condition in which the presence of two or more abnormal cell lines or a normal and an abnormal cell line has observed. Embryonic mosaicism might play a significant role in pregnancy loss after IVF, cytogenetic and array based analysis of miscarriages following spontaneously conceived pregnancies commonly reveal chromosomal mosaicism. The degree of Embryonic Mosaicism negatively affects the implantation rate.
 

• 1.   Le TBP, Nguyen TV, Pham TQ, Le HA, Do QV, Nguyen TTH. Selecting euploid embryo for transfer by preimplantation genetic testing for aneuploidy improved clinical outcomes in patients with advanced maternal age. Biomed Res Ther. 2019;6(12):3541-3549.
• 2.   Dahdouh EM, Balayla J, Garcia-Velasco JA, Kutteh WH. PGT-A for recurrent pregnancy loss: evidence is growing but the issue is not resolved. Hum Reprod. 2021;36(10):2805–2806.
• 3.   Besser AG, Mounts EL. Counselling considerations for chromosomal mosaicism detected by preimplantation genetic screening. Reprod Biomed Online. 2017;34(4):369-374.
• 4.   Taylor TH, Wing R, Griffin DK. A technique to ‘map’ mosaicism at the blastocyst stage using comprehensive chromosome screening. Fertil Steril. 2015;104(3 Suppl):e274.
• 5.   Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18(10):1056–1065.
• 6.   Spinner NB, Conlin LK. Mosaicism and clinical genetics. Am J Med Genet C Semin Med Genet. 2014;166C(4):397–405.
• 7.   Grifo J, Colls P, Ribustello L, Escudero T, Liu E, Munné S. Why do array-CGH (aCGH) euploid embryos miscarry? Reanalysis by NGS reveals undetected abnormalities which would have prevented 56% of the miscarriages. Fertil Steril. 2015;104(3 Suppl):e14.
• 8.   Robberecht C, Schuddinck V, Fryns JP, Vermeesch JR. Diagnosis of miscarriages by molecular karyotyping: benefits and pitfalls. Genet Med. 2009;11(9):646–654.
• 9.   Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373(21):2089–2090.
• 10.   Scott RT Jr, Galliano D. The challenge of embryonic mosaicism in preimplantation genetic screening. Fertil Steril. 2016;105(5):1150–1152.
• 11.   Kleinveld JH, Ten Kate LP, van den Berg M, van Vugt JM, Timmermans DR. Does informed decision making influence psychological outcomes after receiving a positive screening outcome? Prenat Diagn. 2009;29(3):271–273.
• 12.   Huang A, Adusumalli J, Patel S, Liem J, Williams J 3rd, Pisarska MD. Prevalence of chromosomal mosaicism in pregnancies from couples with infertility. Fertil Steril. 2009;91(6):2355–2360.
• 13.   Eggermann T, Soellner L, Buiting K, Kotzot D. Mosaicism and uniparental disomy in prenatal diagnosis. Trends Mol Med. 2015;21(2):77–87.

Data Sharing Statement

Funding